Triple Antibiotic plus Pain Relief Maximum Strength bacitracin zinc, neomycin sulfate, polymyxin b sulfate and pramoxine hydrochloride 500 [USP'U]/g; 3.5 mg/g; 10000 [USP'U]/g; 10 mg/g Ointment — NDC 68016-715-01 (Billing 68016-0715-01)
This is a package of Triple Antibiotic plus Pain Relief Maximum Strength bacitracin zinc, neomycin sulfate, polymyxin b sulfate and pramoxine hydrochloride 500 [USP'U]/g; 3.5 mg/g; 10000 [USP'U]/g; 10 mg/g Ointment from Chain Drug Consortium, LLC, marketed since Jul 2015 and currently FDA-listed, this package's marketing is listed to end Dec 2026. It is this product's only package size.
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 047690
- GCN: 12623
- HICL (First Databank): 035595
- AHFS class code: 08:12.02.00
- RxCUI (RxNorm): 1359350
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 1, 2026
RxNorm drug class
This medicine belongs to the Other antibiotics for topical use class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Oct 1, 2026
Clinical
This is an over-the-counter topical ointment that combines three antibiotic ingredients (bacitracin zinc, neomycin sulfate, and polymyxin B sulfate) with a local anesthetic. The three antibiotics are typically used together in first-aid products to help prevent bacterial infection in minor cuts, scrapes, and wounds. Pramoxine hydrochloride functions as a topical pain reliever commonly included in such products to reduce minor discomfort associated with minor skin injuries.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Oct 1, 2026
- FDA label on DailyMed · label index refreshed Oct 1, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per g | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 2, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 68016-0715-01 You're viewing this Main listing | 1 TUBE in 1 CARTON / 28 g in 1 TUBE | 2015-07-10 | Dec 31, 2026 | Active |
Therapeutic equivalents
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- FDA Orange Book · refreshed Sep 3, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Sep 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Oct 1, 2026
- FDA openFDA NDC Directory · synced Oct 1, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Oct 1, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Uses First aid to help prevent infection and for the temporary relief of pain in minor cuts scrapes burns
⏱️ Dosage and Administration ▾
Directions Adults and children 2 years of age and older clean affected area apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily may be covered with a sterile bandage Children under 2 years of age: ask a doctor
⚠️ Warnings ▾
Warnings For external use only Do not use if you are allergic to any of the ingredients in the eyes over large areas of the body Ask a doctor before use if you have deep or puncture wounds animal bites serious burns Stop use and ask a doctor if you need to use longer than one week condition persists or gets worse rash or other allergic reaction develops symptoms persist for more than one week, or clear up and occur again within a few days Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
📦 Storage and Handling ▾
Other information Store at 15°-30°C (59°-86°F) Before using any medication, read all label directions. Keep carton, it contains important information.
🧪 Active Ingredient ▾
Active ingredients (in each gram) Bacitracin zinc, USP 500 units Neomycin 3.5 mg Polymyxin B sulfate, USP 10,000 units Pramoxine hydrochloride, USP 10 mg
🧪 Inactive Ingredients ▾
Inactive ingredient white petrolatum
🎯 Purpose ▾
Purposes First aid antibiotic Pain reliever
📄 Do Not Use ▾
Do not use if you are allergic to any of the ingredients in the eyes over large areas of the body
📄 Ask a Doctor Before Use If ▾
Ask a doctor before use if you have deep or puncture wounds animal bites serious burns
📄 Stop Use and Ask a Doctor If ▾
Stop use and ask a doctor if you need to use longer than one week condition persists or gets worse rash or other allergic reaction develops symptoms persist for more than one week, or clear up and occur again within a few days
📄 Keep Out of Reach of Children ▾
Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
📄 Questions or Comments ▾
Questions or comments? Call 1 -877-753-3935 Monday-Friday 9AM-5PM EST
📄 Package Label / Principal Display Panel ▾
Principal display panel COMPARE TO THE ACTIVE INGREDIENTS IN NEOSPORIN® + PAIN RELIEF OINTMENT* maximum strength Triple Antibiotic + PAIN RELIEF Bacitracin Zinc • Neomycin Sulfate • Polymyxin B Sulfate • Pramoxine HCl Soothe Painful Cuts, Burns and Scrapes 24 Hour Infection Protection Dual Action *This product is not manufactured or distributed by Johnson & Johnson Consumer, Inc., Distributor of Neosporin® + Pain Relief Ointment. Distributed by: Pharmacy Value Alliance, LLC 407 East Lancaster Avenue, Wayne, PA 19087
Package label PREMIER VALUE Maximum Strength Triple Antibiotic + Pain Relief Bacitracin zinc, USP 500 units, Neomycin 3.5 mg, Polymyxin B sulfate, USP 10,000 units, Pramoxine hydrochloride, USP 10 mg
Reported adverse events (FAERS)
Top reported reactions
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |